PMC:7600245 / 43102-43361
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T169 | 180-188 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T620 | 70-88 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
| T621 | 90-100 | Chemical | denotes | ivermectin | http://purl.obolibrary.org/obo/CHEBI_6078 |
| T622 | 102-111 | Chemical | denotes | ribavirin | http://purl.obolibrary.org/obo/CHEBI_63580 |
| T623 | 112-122 | Chemical | denotes | ivermectin | http://purl.obolibrary.org/obo/CHEBI_6078 |
| T624 | 127-137 | Chemical | denotes | atazanavir | http://purl.obolibrary.org/obo/CHEBI_37924 |
| T625 | 138-147 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T324 | 0-259 | Sentence | denotes | Currently, nitazoxanide is being studied alone or in combination with hydroxychloroquine, ivermectin, ribavirin/ivermectin, or atazanavir/ritonavir for the prevention/treatment of COVID-19 in about 17 clinical trials (for details refer to clinicaltrials.gov). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1307 | 11-23 | Chemical | denotes | nitazoxanide | MESH:C041747 |
| 1308 | 70-88 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 1309 | 90-100 | Chemical | denotes | ivermectin | MESH:D007559 |
| 1310 | 102-111 | Chemical | denotes | ribavirin | MESH:D012254 |
| 1311 | 127-137 | Chemical | denotes | atazanavir | MESH:D000069446 |
| 1312 | 138-147 | Chemical | denotes | ritonavir | MESH:D019438 |
| 1317 | 180-188 | Disease | denotes | COVID-19 | MESH:C000657245 |